Antibiotic treatment of experimental pneumonic plague in mice

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 675-681

  Byrne, William R ^a,e   Welkos, Susan L ^a   Pitt, M Louise ^a   Davis, Kelly J ^a,b   Brueckner, Ralf P ^a,c   Ezzell, John W ^a   Nelson, Gene O ^a,d   Vaccaro, Joseph R ^a,d   Battersby, Luann C ^a   Friedlander, Arthur M ^a  

^a Dept of Immunol and Molec Biology Bldg 1425 U States Army Med R   (United States)

^b U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d ATTN: MCMR UIB G ^*  (United States)

^e UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFOTETAN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; NETILMICIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; SURVIVAL RATE; YERSINIA PESTIS;

EID: 0031941658     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.675     Document Type: Article

References (46)

1. Anderson, G. W., Jr., S. E. C. Leary, E. D. Williamsun, R. W. Titball, S. L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64:4580-4585.
2. Bonacorsi, S. P., M. R. Scavizzi, A. Guiyoule, J. H. Amouroux, and E. Carniel. 1994. Assessment of a fluoroquinolone, three β-lactams, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob. Agents Chemother. 38:481-486.
3. Bucklin, S. E., P. Lake, L. Lögdberg, and D. C. Morrison. 1995. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Antimicrob. Agents Chemother. 39:1462-1466.
4. Butler, T. 1995. Yersinia species (including plague), p. 2075. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
5. Butler, T. 1983. Plague and other Yersinia infections, p. 178-182. In W. S. Greenough III and T. C. Merigan (ed.), Current topics in infectious disease, 1st ed. Plenum Publishing Corporation, New York, N.Y.
6. Butler, T., J. Levin, N. N. Linn, D. M. Chau, M. Adickman, and K. Arnold. 1967. Yersinia pestis infection in Vietnam. II. Quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J. Infect. Dis. 133:493-499.
7. Centers for Disease Control and Prevention. 1992. Pneumonic plague - Arizona. Morbid. Mortal. Weekly Rep. 41:737-739.
8. Centers for Disease Control and Prevention. 1994. Update: human plague - India. Morbid. Mortal. Weekly Rep. 43:761-762.
9. Centers for Disease Control and Prevention. 1997. Fatal human plague - Arizona and Colorado, 1996. Morbid. Mortal. Weekly Rep. 46:617-620.
10. Christ, W. J., O. Asano, A. L. C. Robidoux, et al. 1995. E5531. a pure endoloxin antagonist of high potency. Science 268:80-83.
11. Crook, L. D., and B. Tempest. 1992. Plague: a clinical review of 27 cases. Arch. Intern. Med. 152:1253-1256.
12. Crosby, H. A., J. F. Bion, C. W. Penn, and T. S. Elliott. 1994. Antibiotic-induced release of endotoxin from bacteria in vitro. J. Med. Microbiol. 40:23-30.
13. Davis, K. J., P. Vogel, D. L. Fritz, et al. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice. Arch. Pathol. Lab. Med., in press.
14. Demczar, D. J., A. N. Nafziger, and J. S. Bertino, Jr. 1997. Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing. Antimicrob. Agents Chemother. 41:1115-1119.
15. Dofferhoff, A. S. M., J. H. Nuland, H. G. de Vries-Hospers, P. O. M. Mulder, J. Weits, and V. J. J. Bom. 1991. Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in-vitro and in-vivo study. Scand. J. Infect. Dis. 23:745-754.
16. Doll, J. M., P. S. Zeitz, P. Ettestad, A. L. Bucholz, T. Davis, and K. Gage. 1994. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am. J. Trop. Med. Hyg. 51:109-114.
17. Drusano, G. L. 1995. Pharmacocology of anti-infective agents, p. 225-233. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
18. Edberg, S. C. 1986. The measurement of antibiotics in human body fluids: techniques and significance, p. 382-399. In V. Lorian (ed.). Antibiotics in laboratory medicine, 2nd ed. Williams and Wilkins, Baltimore, Md.
19. Frean, J. A., L. Arntzen, T. Capper, A. Bryskier, and K. P. Klugman. 1996. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrob. Agents Chemother. 40:2646-2647.
20. Friedlander, A. M., S. L. Welkos, P. L. Worsham, et al. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21(Suppl.):5178-5181.
21. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed., p. 1-14. Marcel Dekker, New York, N.Y.
22. Guyton, A. C. 1947. Measurement of the respiratory volumes of laboratory animals. Am. J. Physiol. 150:70-77.
23. Hull, H. F., J. M. Montes, and J. M. Mann. 1987. Septicemic plague in New Mexico. J. Infect. Dis. 155:113-118.
24. Hurley, J. C. 1992. Antibiotic-induced release of endotoxin: a reappraisal. Clin. Infect. Dis. 15:840-854.
25. Kalininskiy, N. T., N. T. Vasil'yev, and S. M. Yudin. 1989. Effectiveness of quinolones against Y. pestis. Antibiot. Khimioter. 34:521-523.
26. Kasatkina, I. V., A. I. Shcherbanyuk, L. N. Makarovskaya, and E. N. Padeiskaya. 1993. Efficacy of the new quinolones - ciprofloxacin and pefloxacin - in experimental plague. Antibiot. Khimioter. 38:42-45.
27. Kusser, W. C., and E. E. Ishiguro. 1988. Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli. Antimicrob. Agents Chemother. 32:1247-1250.
28. Makarovskaya, L. N., V. V. Ryzhkova, V. A. Zurbayan, O. K. Bugayeva, V. V. Pasyukov, I. P. Fomina, and S. M. Navashin. 1995. Comparative efficacy of parenteral and oral use of rifampicin to treat experimental plague in albino mice. Antibiot. Khimioter. 40:37-39.
29. May, K. R. 1973. The Collison nebulizer: description, performance and applications. J. Aerosol Sci. 4:235-243.
30. McClean, K. L. 1995. An outbreak of plague in northwestern province, Zambia. Clin. Infect. Dis. 21:650-652.
31. McCrumb, F. R., S. Mercier, J. Robic, M. Bouillat, J. E. Smadel, T. E. Woodward, and K. Goodner. 1953. Chloramphenicol and terramycin in the treatment of pneumonic plague. Am. J. Med. 14:284-293.
32. Nguyen, V.-A., D.-H. Nguyen, V.-D. Pham, and V.-L. Nguyen. 1973. Cotrimoxazole in bubonic plague. Br. Med. J. iv:108-109.
33. Nitsche, D., C. Schulze, S. Oesser, A. Dalhoff, and M. Sack. 1996. Impact of different classes of antimicrobial agents on plasma endotoxin activity. Arch. Surg. 131:192-199.
34. Prins, J. M., S. J. van Deventer, E. J. Kuijper, and P. Speelman. 1994. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob. Agents Chemother. 38:1211-1218.
35. Romanov, V. E., N. T. Vasil'yev, B. A. Shabalin, A. V. Kozhemyako, I. V. Zhivov, and A. V. Yezhov. 1995. Methods of estimating rapid efficacy of chemotherapeutic preparations promising in special prevention and treatment of plague. Antibiot. Khimioter. 40:31-36.
36. Russell, P., S. M. Eley, D. L. Bell, R. J. Manchee, and R. W. Titball. 1996. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice. J. Antimicrob. Chemother. 37:769-774.
37. Ryzhko, I. P., E. D. Samokhodfcina, and T. A. Zhigalova. 1993. Ceftriaxone in the prophylaxis and treatment of experimental plague infection. Antibiot. Khimioter. 38:39-42.
38. Ryzhko, I. V., R. I. Tsuraeva, V. V. Pasyukov, E. D. Samokhodkina, and A. I. Shcherbanyuk. 1996. Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime, and ceftriaxone) in the prophylaxis and treatment of experimental plague in albino mice. Antibiot. Khimioter. 41:35-38.
39. Sahm, D. F., and J. A. Washington II. 1991. Antibacterial susceptibility tests: dilution methods, p. 1105-1116. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of Clinical Microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
40. SAS Institute, Statistical analysis system, version G. SAS Institute, Cary, N.C.
41. Shcherbanyuk, A. I., L. N. Makarovskaya, O. K. Bugayeva, and I. V. Kasatkina. 1992. Anlibiotics of the aminoglycoside group (gentamicin, sisomicin, and amikacin) in the prevention and treatment of experimental plague infection. Antibiot. Khimioter. 37:30-31.
42. Shenep, J. L., R. P. Barton, and K. A. Mogan. 1985. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J. Infect. Dis. 151:1012-1018.
43. Smith, M. D., D. X. Vinh, N. T. T. Hoa, J. Wain, D. Thung, and N. J. White. 1995. In vitro susceptibilities of strains of Yersinia pestis. Antimicrob. Agents Chemother. 39:2153-2154.
44. Tieh, T. H., E. Landauer, F. Miyagawa, G. Kobayashi, and G. Okayasu. 1948. Primary pneumonic plague in Mukden, 1946, and report of 39 cases with 3 recoveries. J. Infect. Dis. 82:52-58.
45. Von Reyn, C. F., A. M. Barnes, N. S. Weber, T. Quan, and W. F. Dean. 1976. Bubonic plague from direct exposure to a naturally infected coyote. Am. J. Trop. Med. Hyg. 25:626-629.
46. Welkos, S. L., K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Friedlander. 1995. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol. 13:299-305.